NFSG
LUCD icon

Newbridge Financial Services Group’s Lucid Diagnostics LUCD Stock Holding History

Newbridge Financial Services Group’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$40 – 1173
2024
Q1 		$40 Buy
+50
New +$65 ﹤0.01% 1158

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newbridge Financial Services Group's LUCD Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of Lucid Diagnostics (LUCD) in Q2 2024, closing a stake of 50 shares — an estimated $40 sold.

Newbridge Financial Services Group first reported a position in LUCD in Q1 2024 and held it in 1 quarter. The position peaked at $40 in Q1 2024. 34 funds tracked by Wall St. Rank hold LUCD as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining Lucid Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 50 Lucid Diagnostics shares in Q2 2024, an estimated $40.
  • Newbridge Financial Services Group first reported a position in Lucid Diagnostics in Q1 2024 and held it in 1 quarter.
  • Newbridge Financial Services Group's Lucid Diagnostics position peaked at $40 in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.